Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Yuval Cohen$373.4M
Market Cap • 24/04/20242009
(há 15 anos)
2014
(10 years ago)
NASDAQ
Listagem
Norwood
Sede • Massachusetts33
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CRBPSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.